245 results on '"Sugulle, Meryam"'
Search Results
2. Gestational diabetes mellitus, follow-up of future maternal risk of cardiovascular disease and the use of eHealth technologies—a scoping review
3. Placental human papillomavirus infections and adverse pregnancy outcomes
4. Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: Bridging epidemiological knowledge into personalized postpartum care and follow-up
5. Fetal-origin cells in maternal circulation correlate with placental dysfunction, fetal sex, and severe hypertension during pregnancy
6. Poor glucose control and markers of placental dysfunction correlate with increased circulating fetal microchimerism in diabetic pregnancies
7. Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control
8. Predelivery placenta-associated biomarkers and computerized intrapartum fetal heart rate patterns
9. Fetal microchimerism and the two-stage model of preeclampsia
10. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction
11. Alterations in maternal sFlt-1 and PlGF: Time to labor onset in term-/late-term pregnancies with and without placental dysfunction
12. Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?
13. The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers
14. Placental Senescence and the Two‐Stage Model of Preeclampsia.
15. Low physical activity levels 1 year after pregnancy complications
16. Retinal oximetry and microvascular assessment after hypertensive pregnancy complications.
17. Functional and structural vascular biomarkers in women 1 year after a hypertensive disorder of pregnancy
18. Placental dysfunction and increased fetal cell transfer: providing long-lasting cardiovascular messages to the mother?
19. Abstract P208: Cardiovascular Effects Of Antihypertensive Agents In A Rat Model Of Preeclampsia.
20. Maternal haemodynamics in Hypertensive Disorders of Pregnancy under antihypertensive therapy (HyperDiP): study protocol for a prospective observational case–control study
21. Preeclampsia, the placenta, ethnicity, and social determinants of health.
22. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia
23. Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum
24. Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes
25. Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies
26. Circulating angiotensin II type I receptor – autoantibodies in diabetic pregnancies
27. Placental Transcriptome Profiling in Subtypes of Diabetic Pregnancies Is Strongly Confounded by Fetal Sex
28. Classical Cardiovascular Risk Markers in Pregnancy and Associations to Uteroplacental Acute Atherosis
29. Different pathways for preterm birth between singleton and twin pregnancies: a population‐based registry study of 481 176 nulliparous women
30. Disturbed trophoblast transition links preeclampsia progression from placenta to the maternal syndrome
31. Long-term health after hypertensive pregnancy complications: Associations between adverse adiposity indices and dyslipidemia 1–3 years postpartum.
32. Different pathways for preterm birth between singleton and twin pregnancies: a population‐based registry study of 481 176 nulliparous women.
33. Additional file 1 of The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers
34. Additional file 3 of The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers
35. Cardiovascular risk markers in pregnancies complicated by diabetes mellitus or preeclampsia
36. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia
37. Corrigendum to “Decidua basalis and acute atherosis: Expression of atherosclerotic foam cell associated proteins” [Placenta 107 (2021) 1–7]
38. Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health
39. Plasma calprotectin as inflammation marker in pregnancies complicated by diabetes mellitus and superimposed preeclampsia
40. Prospective assessment of vacuum deliveries from midpelvic station in a tertiary care university hospital: Frequency, failure rates, labor characteristics and maternal and neonatal complications
41. P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy
42. Abstract P226: Transcriptome Signature Of Placentas From Diabetic Pregnancies Is Confounded By Fetal Sex.
43. Fetal microchimerism (FMc) correlates with both stages of the two-stage model of preeclampsia – A potential link to future maternal cardiovascular risk?
44. Kidney Injury Caused by Preeclamptic Pregnancy Recovers Postpartum in a Transgenic Rat Model
45. Circulating HLA-G and its association with cardiovascular markers in pregnancy
46. The association between placenta‐associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post‐date pregnancies
47. Circulating angiogenic profiles and histo-morphological placental characteristics of uncomplicated post-date pregnancies
48. Corrigendum to “Low physical activity levels 1 year after pregnancy complications” [Pregnancy Hyperten. 25 (2021) 136–142]
49. Biopsy helpful in diagnosing a liver mass in pregnancy: focal nodular hyperplasia
50. Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.